Products
Since its inception, APTYS has proposed developments on proprietary technologies with a focus on the final product. Among those technologies, Adhapt® and Bi-Gel are currently marketed and evaluated in Clinical Phase III respectively. A new technolgy was recently developed, SPI for soft process implant which is a injectable depot formulation suitable for proteins administration.